https://www.marketscreener.com/quote/stock/NOVAVAX-INC-58256108/news/Swissmedic-Authorizes-Novavax-Nuvaxovid-COVID-19-Vaccine-for-Adolescents-Aged-12-Through-17-and-as-a-41697159/?utm_source=telegram&utm_medium=social&utm_campaign=share